Kevin is an entrepreneur and angel investor.
Presently, he is Founder-CEO of Vivo Diagnostics, a Singapore-based healthcare company specialising in the manufacture of next-generation medical devices for the developing world.
Kevin was previously the Asian Investment Director of Excalibur Group Holdings, the UK’s pre-eminent medical sciences private equity investment firm, where he was responsible for venture capital investments in Southeast Asia and the Middle East. Further to Kevin’s experience in private equity and start-up/growth capital raising, his other areas of commercial experience include corporate rebranding, marketing and operational restructuring.
Kevin’s concurrent appointments include being Co-Founder & Executive Producer of the Metropolitan Festival Orchestra (Singapore), Management Committee Member of PathoVax, LLC (USA), Management Board Member of the Kanok Group (Thailand) and Advisor to the Global Green Economic Consulting Group (Hong Kong/Singapore).
Kevin holds a PhD in Biomedical Engineering from Imperial College London (Hamlyn Centre/Institute of Global Health Innovation) and a BSc (Honours) in Molecular Cell Biology from University College London in the United Kingdom.